CN118973561A - 水性组合物 - Google Patents

水性组合物 Download PDF

Info

Publication number
CN118973561A
CN118973561A CN202380029644.0A CN202380029644A CN118973561A CN 118973561 A CN118973561 A CN 118973561A CN 202380029644 A CN202380029644 A CN 202380029644A CN 118973561 A CN118973561 A CN 118973561A
Authority
CN
China
Prior art keywords
aqueous composition
acid
sodium
present
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380029644.0A
Other languages
English (en)
Chinese (zh)
Inventor
织谷利香
木谷智世
西本明功
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsubota Laboratory Inc
Original Assignee
Tsubota Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Laboratory Inc filed Critical Tsubota Laboratory Inc
Publication of CN118973561A publication Critical patent/CN118973561A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN202380029644.0A 2022-03-25 2023-03-24 水性组合物 Pending CN118973561A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-050275 2022-03-25
JP2022050275 2022-03-25
PCT/JP2023/011739 WO2023182480A1 (ja) 2022-03-25 2023-03-24 水性組成物

Publications (1)

Publication Number Publication Date
CN118973561A true CN118973561A (zh) 2024-11-15

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380029644.0A Pending CN118973561A (zh) 2022-03-25 2023-03-24 水性组合物

Country Status (14)

Country Link
US (1) US20250213510A1 (cg-RX-API-DMAC7.html)
EP (1) EP4483867A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023182480A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240159636A (cg-RX-API-DMAC7.html)
CN (1) CN118973561A (cg-RX-API-DMAC7.html)
AU (1) AU2023240729A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254664A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002831A1 (cg-RX-API-DMAC7.html)
IL (1) IL315871A (cg-RX-API-DMAC7.html)
MA (1) MA67594B1 (cg-RX-API-DMAC7.html)
MX (1) MX2024011634A (cg-RX-API-DMAC7.html)
PE (1) PE20250746A1 (cg-RX-API-DMAC7.html)
TW (1) TW202400133A (cg-RX-API-DMAC7.html)
WO (1) WO2023182480A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026130361A1 (zh) * 2024-12-17 2026-06-25 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4806956B2 (ja) * 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
EP2698155A1 (en) * 2012-08-16 2014-02-19 Lunamed AG Pharmaceutical unit dosage form comprising 4-phenylbutyric acid
PT3593817T (pt) 2017-03-06 2024-12-17 Tsubota Lab Inc Composição para a utilização na prevenção ou supressão da miopia
EP3603642B1 (en) * 2017-03-27 2024-01-10 Alcon Inc. Pharmaceutical preparation
CN113164421A (zh) 2018-12-18 2021-07-23 参天制药株式会社 含有4-苯基丁酸的老视的治疗或预防剂
CN111024960B (zh) * 2019-12-27 2023-02-17 广州阳普医疗科技股份有限公司 用于高血压血样检测的添加剂、试剂盒和应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026130361A1 (zh) * 2024-12-17 2026-06-25 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法及其用途

Also Published As

Publication number Publication date
EP4483867A1 (en) 2025-01-01
WO2023182480A1 (ja) 2023-09-28
US20250213510A1 (en) 2025-07-03
KR20240159636A (ko) 2024-11-05
MX2024011634A (es) 2024-09-30
IL315871A (en) 2024-11-01
MA67594B1 (fr) 2026-01-30
CL2024002831A1 (es) 2025-01-24
MA67594A1 (fr) 2025-07-31
EP4483867A4 (en) 2026-06-24
TW202400133A (zh) 2024-01-01
JPWO2023182480A1 (cg-RX-API-DMAC7.html) 2023-09-28
AU2023240729A1 (en) 2024-10-03
CA3254664A1 (en) 2025-07-03
PE20250746A1 (es) 2025-03-13

Similar Documents

Publication Publication Date Title
JP5275214B2 (ja) 酸化に不安定な成分を含む眼科用安定組成物
US12350366B2 (en) Aqueous ophthalmic solutions of phentolamine and medical uses thereof
JP2025142313A (ja) ソフトコンタクトレンズ用眼科組成物
TW202400133A (zh) 水性組成物
Eagle et al. The Nutritional Requirements of Treponemata: I. Arginine, Acetic Acid, Sulfur-containing Compounds, and Serum Albumin as Essential Growth-promoting Factors for the Reiter Treponeme
JP2003190249A (ja) 洗眼用具
JP5927045B2 (ja) 眼科用水性組成物
HK40113837A (en) Aqueous composition
JP2025011339A (ja) 摩擦低減用であるコンタクトレンズ用点眼剤、その使用方法、および装用中のコンタクトレンズの摩擦低減方法
WO2024203727A1 (ja) 水性組成物
CN100512818C (zh) 配合隐形眼镜使用的组合物及其应用
CN121866052A (zh) 水性组合物
CA3305276A1 (en) Aqueous composition
JP2007277233A (ja) 眼科用組成物
JP2019142855A (ja) 点眼剤
EP4534082A1 (en) Ophthalmic composition
HK40115979A (en) Ophthalmic composition
EP4534081A1 (en) Ophthalmic composition
WO2025053216A1 (ja) 眼科組成物
JP2000281563A (ja) 眼科用液剤
HK1171380A1 (en) Ophthalmic composition
HK1171380B (en) Ophthalmic composition
JP2010090119A (ja) シリコーンハイドロゲルコンタクトレンズ用点眼剤
MXPA97009063A (en) Use of carbonic anhydrase to prepare a composition to increase the blood flow of the retina and composition of the

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40113837

Country of ref document: HK